Brought to you by 
J&J acquires OraPharma for $7.41/share
12 Feb 2003
Executive Summary
In an all-stock transaction, J&J's McNeil Specialty Products company has acquired six-year-old oral health products developer OraPharma and will run it as part of its oral and women's health business, Personal Products Co.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J acquires OraPharma for $7.41/share
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice